Track Category Sponsored by WCG
1:30 – 2:30
Hidden Costs: Remote Monitoring & How to Budget for It
As industry continues to embrace and transition to remote monitoring, the potential staffing and financial burdens on sites mount. This session will help you evaluate the costs and value-add of remotely monitored trials, and understand what line items to keep in mind when negotiating study contracts and budgets.
Jennifer Bush, Sr. Director, Life Sciences Product Strategy, Oracle
Ryan Jones, MBA, CEO, Florence Healthcare
Heather Kemp, Consultant, Trial Capabilities Business Operations, Lilly
Al Peters, Managing Partner, ClinX
2:45 – 3:45
Lessons from the Trenches: How COVID-19 Reshaped Study Budgets
The entire world, including the clinical research industry, has been turned upside down by the COVID-19 pandemic. With trials halted or closed to new enrollments, increased remote monitoring, staff lay-offs and more, we have entered a new paradigm that we must learn to navigate. Looking in the rearview mirror shows us new budget considerations that must be accommodated. This session will help you navigate “the new normal” so you are prepared and informed in the future.
Catherine Click, Director, Clinical Pricing & Analysis, Greenphire
Eric Cole, Local Study Manager, AstraZeneca
Karen McIntyre, MSc, 1st Executive Director, Syneos Health
Steve Satek, MBA, Founder & President, Great Lakes Clinical Trials